Silo Pharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Silo Pharma Inc.
- Former names
- Uppercut Brands, Inc. Point Capital, Inc. Gold Swap Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Sarasota
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SILO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001514183
- EIN
- 46-2137136
Board of directors
-
Eric Weisblum · Director · Chief Executive OfficerSince 2023
-
Jeff Pavell · DirectorSince 2025
-
Kevin Munoz · DirectorSince 2025
-
Wayne Linsley · DirectorSince 2025
Chief executives
Eric Weisblum
· CEO and President
Dates unknown
Director election results
Annual meeting of August 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.0%
-
98.0%
-
98.0%
-
98.0%
Board connections
2 of this board's directors also sit on 2 other boards.
- via Jeff Pavell and Wayne Linsley
- via Wayne Linsley
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $7,660
- 6 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Eric Weisblum Director, Officer (Chief Executive Officer) | Open-market purchase | +2,500 | $0.41 | $1,025 |
| Dec 15, 2025 | Eric Weisblum Director, Officer (Chief Executive Officer) | Open-market purchase | +2,500 | $0.42 | $1,050 |
| Nov 21, 2025 | Eric Weisblum Director, Officer (Chief Executive Officer) | Open-market purchase | +1,000 | $0.37 | $370 |
| Nov 20, 2025 | Eric Weisblum Director, Officer (Chief Executive Officer) | Open-market purchase | +1,000 | $0.37 | $370 |
| Nov 19, 2025 | Eric Weisblum Director, Officer (Chief Executive Officer) | Open-market purchase | +4,500 | $0.41 | $1,845 |
| Nov 18, 2025 | Eric Weisblum Director, Officer (Chief Executive Officer) | Open-market purchase | +7,500 | $0.40 | $3,000 |
| May 27, 2025 | Eric Weisblum Director, Officer (Chief Executive Officer) | Open-market purchase | +10,000 | $0.43 | $4,300 |
| Dec 13, 2024 | Eric Weisblum Director, Officer (CEO and President) | Open-market purchase | +2,500 | $0.84 | $2,100 |
| Nov 22, 2024 | Eric Weisblum Director, Officer (CEO and President) | Open-market purchase | +2,500 | $0.90 | $2,250 |
| Nov 20, 2024 | Eric Weisblum Director, Officer (CEO and President) | Open-market purchase | +2,500 | $0.95 | $2,375 |
| Jun 12, 2024 | Eric Weisblum Director, Officer (CEO and President) | Open-market purchase | +4,438 | $1.11 | $4,926 |
| Jun 11, 2024 | Eric Weisblum Director, Officer (CEO and President) | Open-market purchase | +562 | $1.08 | $607 |
| Apr 5, 2024 | Eric Weisblum Director, Officer (CEO and President) | Open-market purchase | +400 | $2.03 | $812 |
| Apr 4, 2024 | Eric Weisblum Director, Officer (CEO and President) | Open-market purchase | +600 | $1.96 | $1,176 |
| Apr 1, 2024 | Eric Weisblum Director, Officer (CEO and President) | Open-market purchase | +1,100 | $1.91 | $2,101 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.